Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
The living legacy of the Global Plan: eliminating HIV in children

The Journal of Acquired Immune Deficiency Syndromes (JAIDS) has released a special supplement on the incredible journey of the Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive (Global Plan), which documents the history of the Global Plan and outlines what the future holds as efforts to end AIDS among women, children and adolescents accelerate.

Published
20 April 2017
From
UNAIDS
Defective HIV proviruses hinder immune system response and cure

HIV proviruses can outnumber functional HIV 1000 copies to one and the faulty proteins they create can complicate efforts to measure a patient's viral load, exhaust immune systems, shield functional HIV from attack by natural means or drugs, and seriously complicate the development of a cure.

Published
19 April 2017
From
Science Daily
Orphan Drug Designation for CytoDyn's PRO 140 Declined by the FDA

Cytodyn has announced that its application for Orphan Drug Designation (ODD) for PRO 140 was not granted by the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) because PRO 140 appears to have the potential to treat more than just the subset of multi-drug resistant HIV patients for which the designation was requested.

Published
18 April 2017
From
Cytodyn press release
Biomarker Opens New Door in HIV Cure Research

For the first time, investigators have found a biomarker that identifies some cells latently infected with HIV.

Published
14 April 2017
From
MedPage Today HIV/AIDS
We asked a scientist to explain CRISPR to us—and how it’s being used in HIV research

Perhaps you’ve heard about a research technology called CRISPR (pronounced “crisper”) in the news. Since the technology was first developed, it has generated headlines as thousands of researchers have adopted this technology as a way to edit the genes of plant, animal and human cells.

Published
12 April 2017
From
BETA blog
Health system navigators didn't improve ART initiation or TB treatment completion rates among people newly diagnosed with HIV in Durban

An intervention using health system navigators, phone support and text message reminders did not improve rates of people living with HIV initiating antiretroviral therapy (ART) or completing treatment

Published
10 April 2017
By
Michael Carter
Suicide accounts for 2% of deaths in people with HIV, twice the rate of the general population

Men living with HIV have an elevated rate of suicide, particularly in the first year after diagnosis, according to a fifteen-year study of almost 90,000 people diagnosed

Published
06 April 2017
By
Roger Pebody
How AIDS denialism spreads in Russia through online social networks

Three important factors for participation in AIDS denialist networks were determined: inadequate counselling, denial of the diagnosis because informants “felt good” and unwillingness to follow antiretroviral treatment. To our surprise, we found that the two most-known and hotly debated AIDS denial rhetorical strategies – that HIV science is fake and that it is a product of a global conspiracy – played almost no role in converting individuals to AIDS denialism.

Published
05 April 2017
From
The Conversation
Nurse-led intervention improves adherence to ART and is cost-effective

An antiretroviral therapy (ART) adherence support study conducted in the Netherlands has been hailed as “an outstanding addition to the scientific literature on adherence.” Published

Published
28 March 2017
By
Michael Carter
Frame PrEP as part of a ‘healthy sex life’ for better adherence

Brief, empowering messaging around pre-exposure prophylaxis (PrEP) can lead to better medication adherence, new research has found. When PrEP counselors framed PrEP as part of a healthy sex life, new PrEP clients were significantly more likely to have high levels of adherence to the medication. This was true even among demographics that typically struggle with adherence including young people and people of color.

Published
27 March 2017
From
BETA blog

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.